•
Sep 30, 2023

Ascendis Pharma Q3 2023 Earnings Report

Total Revenue
$52.3M
Previous year: $15.4M
+239.0%
EPS
-$3.13
Previous year: -$3.05
+2.6%
Gross Profit
$39.1M
Cash and Equivalents
$482M
Free Cash Flow
-$138M
Total Assets
$925M

Ascendis Pharma

Ascendis Pharma